All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @fuckyeaherikamoen on Instagram · 67s|Watch on Instagram
Full video transcriptClick to expand

Auto-generated transcript of @fuckyeaherikamoen's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00We are young, we wanna bring
  2. 0:04We want tea, nice and clean
  3. 0:07See our friends, see the size
  4. 0:10Feel alright
  5. 0:13Here we go, we go well
  6. 0:16Smoke and play, put it out
  7. 0:20See our friends, see the size
  8. 0:23Feel alright
  9. 0:26Now we like you, I can be sure
  10. 0:32I'll be seen as she turns
  11. 0:35We are strange in our own spot
  12. 0:39We are young, we're getting by
  13. 0:42Not gonna make it, make your time
  14. 0:45Slip around, if we're lonely
  15. 0:49Then we're alright
  16. 0:52We're going to catch
  17. 0:54We're going to miss the wheels
  18. 0:56We're going to miss the wheels
  19. 0:59We're strong
  20. 1:01We're going to ride
  21. 1:03We're alright

Erika Moen's menopause story: what she got right and wrong

Erika Moen

Instagram creator

23.4K viewsView on Instagram

Quick answer

The caption describes a symptom pattern consistent with perimenopause-related hormone fluctuation, specifically cognitive impairment and severe fatigue beginning at age 35, though the video transcript contains no clinical content to evaluate. The TRT categorization creates ambiguity about whether the implied treatment was estrogen, testosterone, or both, and these interventions have meaningfully different evidence profiles in perimenopausal women. Any patient presenting with this symptom cluster should have thyroid function, autoimmune markers, and sleep disorders ruled out before attributing symptoms to perimenopause alone.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Erika Moen's menopause story: what she got right and wrong, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Erika Moen's menopause story: what she got right and wrong is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Erika Moen's menopause story: what she got right and wrong" from Erika Moen. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The caption describes a symptom pattern consistent with perimenopause-related hormone fluctuation, specifically cognitive impairment and severe fatigue beginning at age 35, though the video transcript contains no clinical content to evaluate.

The reason this review is not generic is the source wording and the canonical claim label "trt when i was about 35 my body started failing me my brain wa." In this clip, the useful excerpt is: "We are young, we wanna bring We want tea, nice and clean See our friends, see the size Feel alright Here we go, we go well Smoke and play, put it out See our friends, see the size Feel alright Now we like you, I can be sure I'll be seen as..." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Severe fatigue and brain fog in perimenopausal women are supported by research.
People who land here are usually comparing the Testosterone claim with erikamoen, estrogen, and estrogenpatch.
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The caption describes a symptom pattern consistent with perimenopause-related hormone fluctuation, specifically cognitive impairment and severe fatigue beginning at age 35, though the video transcript contains no clinical content to evaluate.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The caption describes a symptom pattern consistent with perimenopause-related hormone fluctuation, specifically cognitive impairment and severe fatigue beginning at age 35, though the video transcript contains no clinical content to evaluate. The TRT categorization creates ambiguity about whether the implied treatment was estrogen, testosterone, or both, and these interventions have meaningfully different evidence profiles in perimenopausal women. Any patient presenting with this symptom cluster should have thyroid function, autoimmune markers, and sleep disorders ruled out before attributing symptoms to perimenopause alone.
  • Perimenopause can begin in the early-to-mid 30s. The SWAN study followed women from age 42 on average, but clinical case series document earlier onset in a meaningful subset of patients.
  • Severe fatigue and brain fog in perimenopausal women are supported by research. Avis et al. (2015, JAMA Internal Medicine) found fatigue significantly elevated in early perimenopause independent of mood disorders.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Perimenopause can begin in the early-to-mid 30s. The SWAN study followed women from age 42 on average, but clinical case series document earlier onset in a meaningful subset of patients.
  • Severe fatigue and brain fog in perimenopausal women are supported by research. Avis et al. (2015, JAMA Internal Medicine) found fatigue significantly elevated in early perimenopause independent of mood disorders.
  • A single normal FSH or estradiol result does not rule out perimenopause. Hormone levels fluctuate widely during the transition, and serial testing is more informative.
  • Estrogen therapy has peer-reviewed support for cognitive and vasomotor symptoms in perimenopause. Testosterone therapy for fatigue in women is off-label with a weaker evidence base as of Davis et al. (2019, Lancet Diabetes and Endocrinology).
  • Hypothyroidism, autoimmune conditions, and sleep apnea can mimic perimenopause symptoms exactly. The Endocrine Society recommends excluding these before attributing symptoms to hormonal transition.
  • The TRT and estrogen therapy categories are not interchangeable. Conflating them in content metadata creates real confusion about risk profiles, monitoring requirements, and regulatory status.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @fuckyeaherikamoen actually say?

Straightforwardly: not much that's medically verifiable. The transcript attached to this video is song lyrics, not a spoken explanation of hormone therapy or perimenopause symptoms. The caption tells a real and relatable story about brain fog, extreme fatigue, and repeated work absences starting around age 35, with doctors finding nothing wrong. But the video content itself doesn't deliver a health claim we can fact-check line by line.

The caption mentions she was "passed out on the couch for a week at a time" and that doctors "couldn't find anything wrong." Those are the actual claims in play here. The hashtags, including estrogenpatch, hrt, and perimenopause, strongly imply that HRT resolved her symptoms, but she doesn't say that explicitly in what was transcribed. We're fact-checking the framing, not a lecture.

Does the science back this up?

The symptoms she describes in the caption, specifically cognitive fog, severe fatigue, and functional impairment starting in the mid-30s, are clinically consistent with perimenopause. Research supports this connection, even if most doctors still don't recognize perimenopause as a possible culprit in women under 40.

A 2019 study by Maki and Henderson in the journal Menopause confirmed that cognitive symptoms including brain fog are common in the perimenopause transition and are tied to fluctuating estradiol levels, not just the absence of estrogen. Weber et al. (2013, Psychoneuroendocrinology) found that verbal memory and processing speed declined measurably during perimenopause compared to premenopausal baselines. The fatigue picture is similar. Avis et al. (2015, JAMA Internal Medicine) followed over 3,000 women and found persistent fatigue was significantly more common in early perimenopause than in premenopausal women, independent of depression or sleep disorders. So the symptom profile she describes is real and documented. Her frustration with doctors missing it is also well-founded. Studies show perimenopause is systematically under-diagnosed, especially in women under 40.

What did they get wrong (or right)?

She got the symptom framing right. Debilitating fatigue and brain fog in the mid-30s, dismissed by doctors, is a documented clinical pattern. That part is accurate and worth amplifying.

What we can't evaluate is whether HRT actually fixed it. The hashtags imply it did, but the transcript doesn't make that claim, so we can't call it wrong either. What would be misleading is if viewers take away the message that estrogen patches are a guaranteed fix for these symptoms without further workup. Other conditions, including hypothyroidism, autoimmune disease, and sleep apnea, can produce an identical symptom cluster. The Endocrine Society guidelines recommend ruling those out before attributing symptoms solely to perimenopause. The video also sits under a TRT category, which is odd. Testosterone therapy is sometimes used off-label in perimenopausal women for fatigue and libido, but the evidence base is much weaker than for estrogen. Davis et al. (2019, Lancet Diabetes and Endocrinology) found modest benefits for hypoactive sexual desire but limited data on fatigue specifically. If the implication is that testosterone drove her recovery, that claim needs more support than a hashtag.

What should you actually know?

Perimenopause can start in the early-to-mid 30s. That's not fringe information, it's in the data, but a lot of clinicians still treat it as a problem for women over 45. If you're in your mid-30s with the symptom pattern she describes and your standard labs come back normal, asking a provider specifically about perimenopause hormone testing is reasonable.

A few things worth knowing before assuming HRT is the answer:

  • FSH and estradiol levels can fluctuate widely during perimenopause. A single normal result doesn't rule it out. Repeated testing across a cycle gives a cleaner picture.
  • Estrogen therapy has a real evidence base for vasomotor symptoms and cognitive symptoms in perimenopause. The SWAN study and follow-up analyses support this for appropriately selected patients.
  • Testosterone for perimenopausal fatigue is not FDA-approved in women. Any use is off-label. That doesn't make it wrong, but it means the evidence bar is lower and the monitoring requirements are higher.
  • Content categorized under TRT that's actually about estrogen therapy creates confusion. These are different hormonal interventions with different risk profiles and different evidence bases. Don't treat them as interchangeable.

Her story resonates with a lot of women who felt dismissed. That part is doing real work. The medical specifics just need more than hashtags to stand on.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Erika Moen · Instagram creator

23.4K views on this video

When I was about 35, my body started failing me. My brain was foggy and I was so incredibly weak and tired. I was missing a significant amount of work each month because my body would just shut down a

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about perimenopause can begin in the early-to-mid 30s. the swan study?

Perimenopause can begin in the early-to-mid 30s. The SWAN study followed women from age 42 on average, but clinical case series document earlier onset in a meaningful subset of patients.

What does the video say about severe fatigue?

Severe fatigue and brain fog in perimenopausal women are supported by research. Avis et al. (2015, JAMA Internal Medicine) found fatigue significantly elevated in early perimenopause independent of mood disorders.

What does the video say about a single normal fsh?

A single normal FSH or estradiol result does not rule out perimenopause. Hormone levels fluctuate widely during the transition, and serial testing is more informative.

What does the video say about estrogen therapy has peer-reviewed support for cognitive?

Estrogen therapy has peer-reviewed support for cognitive and vasomotor symptoms in perimenopause. Testosterone therapy for fatigue in women is off-label with a weaker evidence base as of Davis et al. (2019, Lancet Diabetes and Endocrinology).

What does the video say about hypothyroidism, autoimmune conditions,?

Hypothyroidism, autoimmune conditions, and sleep apnea can mimic perimenopause symptoms exactly. The Endocrine Society recommends excluding these before attributing symptoms to hormonal transition.

What does the video say about the trt?

The TRT and estrogen therapy categories are not interchangeable. Conflating them in content metadata creates real confusion about risk profiles, monitoring requirements, and regulatory status.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Erika Moen, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.